| Emily Oravitz, | |
|
2719 Brodhead Rd, Aliquippa, PA 15001-2793 | |
| (724) 378-4411 | |
| Not Available |
| Full Name | Emily Oravitz |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 2719 Brodhead Rd, Aliquippa, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831868108 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RP456115 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Emily Oravitz, 2719 Brodhead Rd, Aliquippa, PA 15001-2793 Ph: () - | Emily Oravitz, 2719 Brodhead Rd, Aliquippa, PA 15001-2793 Ph: (724) 378-4411 |
News Archive
Pain is the most common symptom leading patients to see a physician in the United States, yet the most widely prescribed medications - opioids and non-steroidal anti-inflammatory drugs (NSAIDS) - have major drawbacks, including the potential for misuse and abuse and adverse effects that limit long-term use. While scientists have made great strides in understanding the physical and chemical processes that occur when people feel pain, new treatments with improved safety and effectiveness are still needed for the more than 76 million Americans with acute and chronic pain.
One of the most effective chemotherapy drugs against cancer is cisplatin because it attaches to cancer DNA and disrupts repair. However, it also kills healthy tissue. Many scientists are creating alternative drugs or cisplatin analogs in attempts to find treatments without side effects.
Inspiration Biopharmaceuticals, Inc. today announced the initiation of patient enrollment in the second of two pivotal studies in the Company's OBI-1 Accur8 clinical trial program.
Pfizer Inc. announced that Prevenar 13 (Pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]) was introduced into the first childhood immunization program for pneumococcal disease (PD) in the developing world under the auspices of the Advance Market Commitment (AMC) when Nicaragua launched its program today. The AMC is an innovative program which involves private-public partnerships to help make newer vaccines available on a sustainable, affordable and accelerated basis to the least developed countries.
› Verified 8 days ago
Mrs. Antoniette Barbuto, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2665 Brodhead Rd, Suite B, Aliquippa, PA 15001 Phone: 724-375-1230 | |
Lori Zelesnik, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 143 Turkmar Dr, Aliquippa, PA 15001 Phone: 724-775-5325 | |
Adam Andrew, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2003 Sheffield Rd, Aliquippa, PA 15001 Phone: 180-085-0339 | |
Mrs. Heather Walsh, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2665 Brodhead Rd, Aliquippa, PA 15001 Phone: 724-378-4141 | |
Mr. Gino S. Cordisco, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2003 Sheffield Rd, Aliquippa, PA 15001 Phone: 724-816-2512 Fax: 724-776-7237 | |
Douglas Kaleugher, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2003 Sheffield Rd, Aliquippa, PA 15001 Phone: 724-378-5325 Fax: 724-378-5312 | |
James Conrad Burke, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2003 Sheffield Rd, Suite B, Aliquippa, PA 15001 Phone: 724-375-1672 |